2nd CEE – Webcast

Thursday 6 October
Session 1: Country-specific presentations
 
Local situation in Romania
Dr. O. Sandulescu, Carol Davila University of Medicine and Pharmacy, Romania
 
Local situation in Ukraine
Dr. P. Skala, Alliance for Public Health, Ukraine
 
Local situation in the Baltic countries
Dr. S. Caplinskas, Centre For Communicable Diseases and AIDS, Lithuania
 
Local situation in Slovenia and the Balcan countries
Dr. M. Maticic, University of Ljubljana Medical Faculty, Slovenia
 
Local situation in Poland
Dr. M. Parczewski, Pomeranian Medical University, Poland
 
Local situation in Czech and Slovak Republics
Dr. V. Aster, Hospital Na Bulovce, Czech Republic
 
Local situation in Georgia
Dr. A. Abutidze Infectious Diseases, AIDS and Clinical Immunology Research Center, Georgia
 
Local situation in Turkey
Dr. C. Yurdaydin University of Ankara Medical School, Turkey
 
Local situation in Russia
Dr. V. Rassokhin, Saint-Petersburg City AIDS center, Russia
 Panel discussion
Session 2: Management of Hepatitis B
 
State-of-the-art treatment of Hepatitis B
Dr. C. Yurdaydin, University of Ankara Medical School, Turkey
 
Prospects for Cure
Dr. P. Kennedy, Royal Free Hospital, United Kingdom
Presentation
Discussion
 
Session 3: Management of Hepatitis Delta
 
Update of new drugs
Dr. C. Yurdaydin, University of Ankara Medical School, Turkey
Presentation
Discussion
Friday 7 October
Session 4: Treatment Challenges in HCV -- special populations
 
Intravenous Drug Users
Dr. P. Khaykin, MainFachArzt, Germany
 Drug-Drug Interactions: considerations
Dr. A. Streinu-Cercel, National Institute for Infectious Diseases Prof Dr Matei Bals, Romania
Presentation
Discussion
Special session: HIV in Special Populations (ViiV)
 
Tackling the issues: Caring for HIV-positive women today
Dr. A. M. Geretti, University of Liverpool, Institute of Infection and Global Health, United Kingdom
 
HIV and Pediatrics in Central Europe
Dr. M. Mărdărescu, National Institute for Infectious Diseases Prof Dr Matei Bals, Romania
Session 5 Co-infection
 


Cost-efficiency versus Potency
Dr. A. Streinu-Cercel, National Institute for Infectious Diseases Prof Dr Matei Bals, Romania